Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

CALM vs AQB: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CALM Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 10–0 Matrix Metrics)

CALM Overall Winner 6-Pillar Tally: CALM 6 – 0 AQB Matrix Metrics: CALM 10 – 0 AQB

As of Nov 17, 2026, Cal-Maine Foods Inc (CALM) is the stronger overall head-to-head candidate over AquaBounty Technologies, Inc. (AQB) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CALM carries a Unified Composite Score of 46.3/100 (HOLD) at $65.24 (26.9x Forward P/E, 0.8% operating margin), whereas AQB carries 44.6/100 (HOLD) at $0.82 (N/M Forward P/E, 0.0% operating margin).

  • Technical & Structure Timing Caution: CALM is currently in a Weinstein Distribution regime near a flattening 50-day moving average and Breakdown options structure phase (RSI 48.7); meanwhile AQB is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 37.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CALM vs AQB
CALM NASDAQ Head-to-Head Winner
Cal-Maine Foods Inc
Agricultural Prod-Livestock & Animal Specialties
$65.24
-1.95% 1D
Market Cap $3.1B
TTM Revenue $2.53B
Forward P/E 26.9x
Beta / 30D Vol 0.02β · 44% Vol
Unified Composite Score
46.3 / 100 HOLD
Tech 54.0 Fund 54.0 Flow 57.0 Mom 50.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -8.6%) with fading momentum, RSI 49
RSI-14: 48.7 · SMA20: $64.71 · SMA50: $66.72
AQB NASDAQ
AquaBounty Technologies, Inc.
Fishing, Hunting And Trapping
$0.82
+2.01% 1D
Market Cap $9.7M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.93β · 117% Vol
Unified Composite Score
44.6 / 100 HOLD
Tech 33.0 Fund 49.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -9.5%), weak momentum, RSI 37
RSI-14: 37.5 · SMA20: $1.04 · SMA50: $1.03

6-Pillar Scorecard Institutional Category Breakdown (CALM 6 – 0 AQB)

Columns: Metric · CALM · AQB
1. Valuation Multiples CALM
Forward P/E 26.9x N/M
Trailing P/E 54.1x N/M
PEG Ratio 2.20x N/M
EV / Revenue 1.2x N/M
2. Growth & Scale CALM
Revenue Growth (YoY) -41.5% -93.5%
Earnings Growth (YoY) -89.8% +0.0%
TTM Revenue (USD) $2.53B N/A
Market Cap $3.1B $9.7M
3. Profitability & Quality CALM
Gross Margin 14.3% N/A
Operating Margin 0.8% 0.0%
Net Profit Margin 2.3% 0.0%
Return on Equity (ROE) 2.4% -68.9%
4. Balance Sheet & Cash Flow CALM
Cash Generation (TTM) -$58M -$7.2M
Cash Flow Margin -2.3% N/A
Net Cash / Leverage $54.77 Book/Sh · 2.4% ROE $0.19 Book/Sh · -68.9% ROE
Dividend Yield 1.63% None (0.00%)
5. Options & Positioning CALM
Options Structure Phase BREAKDOWN BREAKDOWN
Current IV / %ile 37.7% (19th %ile) N/A (N/A)
Put/Call OI Skew 0.41x (Call-Skewed) N/A
OBV Trend / Tech Phase DISTRIBUTION · Distribution NEUTRAL · Markdown
6. R&D & Supply-Chain Moat CALM
OpEx & R&D Intensity 13.5% of Rev ($341M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Farm Products Operator Farm Products Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CALM (10) vs AQB (0)
Institutional Metric CALM AQB Criterion Row Edge
Market Capitalization
Scale
$3.1B $9.7M Larger Scale CALM
Trailing P/E Ratio
Valuation
54.1x N/M Lower Multiple CALM
Forward P/E Ratio
Valuation
26.9x N/M Lower Multiple CALM
Revenue Growth (YoY)
Growth
-41.5% -93.5% Higher Growth CALM
Operating Margin (TTM)
Profitability
0.8% 0.0% Higher Margin CALM
Net Profit Margin
Profitability
2.3% 0.0% Higher Margin CALM
Return on Equity (ROE)
Capital Efficiency
2.4% -68.9% Higher ROE CALM
52-Week Range Position
Momentum
15% ($60–$95) 11% ($1–$2) Stronger Trend CALM
Beta / 30D Volatility
Risk Regime
0.02β · 44% Vol 0.93β · 117% Vol Lower Realized Risk CALM
Unified Institutional Score
Composite Signal
46.3 / 100 (HOLD) 44.6 / 100 (HOLD) Higher Composite CALM
Trailing 12M Revenue (USD)
Operating Scale
$2.53B N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
14.3% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
2.20x PEG · 1.2x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$58M ($54.77 Book/Sh · 2.4% ROE) -$7.2M ($0.19 Book/Sh · -68.9% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CALM +26.53 pp
CALM: +5.16% · AQB: -21.37%
3M Horizon CALM +19.5 pp
CALM: -19.01% · AQB: -38.51%
6M Horizon CALM +4.4 pp
CALM: -16.97% · AQB: -21.37%
1Y Horizon AQB +4.32 pp
CALM: -27.89% · AQB: -23.57%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period CALM Revenue AQB Revenue CALM Op. Margin AQB Op. Margin Margin Leader
FY2019 $1.36B $0M 3.4% -7057.3% CALM
FY2020 $1.35B $0M 0.1% -12727.1% CALM
FY2021 $1.35B $0M -1.9% -1883.0% CALM
FY2022 $1.78B $0M 8.1% -711.6% CALM
FY2023 $3.15B $0M 30.8% -552.9% CALM
FY2024 $2.33B N/A 13.4% N/A CALM
FY2025 $4.26B N/A 36.1% N/A CALM
FY2026 $2.91B N/A 12.0% N/A CALM

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CALM BREAKDOWN
78d in phase · OBV DISTRIBUTION
Current IV 37.7%
IV Percentile 19th %ile
Put/Call OI Skew 0.41x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact CALM Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
AQB BREAKDOWN
69d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact AQB Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CALM Moat Profile Cyclical / Execution-Driven Positioning
Farm Products Operator
Competes within the Farm Products value chain with $3.1B market capitalization and 0.8% operating margin.
OpEx & R&D Reinvestment 13.5% of Rev ($341M)
90D Engineering Disclosures 0 Published
AQB Moat Profile Cyclical / Execution-Driven Positioning
Farm Products Operator
Competes within the Farm Products value chain with $9.7M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ CALM vs AQB Key Questions & Quantitative Answers

As of Nov 17, 2026, Cal-Maine Foods Inc (CALM) is the stronger overall head-to-head candidate over AquaBounty Technologies, Inc. (AQB) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CALM carries a Unified Composite Score of 46.3/100 (HOLD) at $65.24 (26.9x Forward P/E, 0.8% operating margin), whereas AQB carries 44.6/100 (HOLD) at $0.82 (N/M Forward P/E, 0.0% operating margin). Technical & Structure Timing Caution: CALM is currently in a Weinstein Distribution regime near a flattening 50-day moving average and Breakdown options structure phase (RSI 48.7); meanwhile AQB is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 37.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

CALM leads the Growth & Scale pillar: CALM posts -41.5% YoY revenue growth and -89.8% YoY earnings growth on $2.53B TTM revenue (14.3% gross margin, 0.8% operating margin), compared with AQB at -93.5% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin). Across the 8-period historical trajectory (FY2019 to FY2026), CALM cumulative revenue shifted +114.0% while AQB shifted N/A. In operating R&D and SG&A reinvestment, CALM deploys 13.5% of Rev ($341M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for AQB.

CALM screens cheaper on headline valuation multiples. CALM trades at 26.9x Forward P/E, 54.1x Trailing P/E, 2.20x PEG, and 1.2x EV/Revenue (-2.3% FCF margin), whereas AQB trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CALM (2.4% ROE) versus AQB (-68.9% ROE) capital efficiency.

In options market volatility and institutional positioning, CALM carries 37.7% implied volatility (19th %ile, Compressed (<25th %ile)), a 0.41x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (0.02β · 44% Vol realized risk). By comparison, AQB carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (0.93β · 117% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.